Kanazawa Hiroshi, Yoshikawa Junichi
Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Abenoku, Japan.
Chest. 2005 Nov;128(5):3191-7. doi: 10.1378/chest.128.5.3191.
The prevalent theory concerning the pathogenesis of COPD is that it is an imbalance between oxidants and antioxidants. However, it has been reported that a decrease in vascular endothelial growth factor (VEGF) might affect the pathogenesis of COPD. Therefore, this study was designed to examine the differences between oxidative stress and VEGF levels, and the severity of COPD.
Controlled cross-sectional analysis.
University hospital.
Twelve healthy control subjects and 57 COPD patients were included in this study. These COPD patients were divided into four groups based on the Global Initiative for Chronic Obstructive Lung Disease classification (mild COPD, 14 patients; moderate COPD, 15 patients; severe COPD, 16 patients; very severe COPD, 12 patients).
Inflammatory markers, degree of oxidative stress, and VEGF levels were examined in sputum samples from all subjects. Nitrogen oxide levels in induced sputum were significantly higher in COPD patients than in healthy control subjects, and they increased with increases in the severity of COPD. In contrast, peroxynitrite inhibitory activity decreased with increases in the severity of COPD. Therefore, the mean (SD) peroxynitrite stress (ie, the nitrogen oxide level/peroxynitrite inhibitory activity ratio) steeply increased with increases in the severity of COPD (mild COPD: 8.4; SD, 1.5; p = 0.02; moderate COPD: 10.8; SD, 1.4; p < 0.0001; severe COPD: 14.5; SD, 2.5; p < 0.0001; very severe COPD: 18.3; SD, 4.1; p < 0.0001) compared with that of healthy control subjects. VEGF levels in induced sputum reciprocally decreased with severity of COPD (mild COPD: 1,360 pg/mL; SD, 800 pg/mL; p = 0.97; moderate COPD: 1,180 pg/mL; SD, 760 pg/mL; p = 0.50; severe COPD: 650 pg/mL; SD, 450 pg/mL; p = 0.007; very severe COPD: 480 pg/mL, SD, 240 pg/mL; p = 0.002). In addition, peroxynitrite inhibitory activity in COPD patients exhibited an accelerated decline from the mean VEGF level in healthy control subjects.
Elevated oxidative stress levels and a reciprocal reduction of VEGF levels in induced sputum were prominent with increases in the severity of COPD. Thus, epithelial cell injury mediated by oxidative stress may induce the decrease in lung VEGF levels, resulting in the promotion of the development of COPD.
关于慢性阻塞性肺疾病(COPD)发病机制的普遍理论认为,其是氧化剂与抗氧化剂之间的失衡。然而,有报道称血管内皮生长因子(VEGF)减少可能影响COPD的发病机制。因此,本研究旨在探讨氧化应激与VEGF水平的差异以及COPD的严重程度。
对照横断面分析。
大学医院。
本研究纳入了12名健康对照者和57例COPD患者。这些COPD患者根据慢性阻塞性肺疾病全球倡议分类分为四组(轻度COPD,14例;中度COPD,15例;重度COPD,16例;极重度COPD,12例)。
检测了所有受试者痰液样本中的炎症标志物、氧化应激程度和VEGF水平。COPD患者诱导痰中的氮氧化物水平显著高于健康对照者,且随COPD严重程度的增加而升高。相反,过氧亚硝酸盐抑制活性随COPD严重程度的增加而降低。因此,与健康对照者相比,过氧亚硝酸盐应激均值(标准差)(即氮氧化物水平/过氧亚硝酸盐抑制活性比值)随COPD严重程度的增加而急剧升高(轻度COPD:8.4;标准差,1.5;p = 0.02;中度COPD:10.8;标准差,1.4;p < 0.0001;重度COPD:14.5;标准差,2.5;p < 0.0001;极重度COPD:18.3;标准差,4.1;p < 0.0001)。诱导痰中的VEGF水平随COPD严重程度的增加而呈反向下降(轻度COPD:1360 pg/mL;标准差,800 pg/mL;p = 0.97;中度COPD:1180 pg/mL;标准差,760 pg/mL;p = 0.50;重度COPD:650 pg/mL;标准差,450 pg/mL;p = 0.007;极重度COPD:480 pg/mL,标准差,240 pg/mL;p = 0.002)。此外,COPD患者的过氧亚硝酸盐抑制活性相对于健康对照者的平均VEGF水平呈现加速下降。
随着COPD严重程度的增加,诱导痰中氧化应激水平升高和VEGF水平相应降低的现象较为突出。因此,氧化应激介导的上皮细胞损伤可能导致肺VEGF水平降低,从而促进COPD的发展。